The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. General Cardiovascular Medicine
Volume 12 - 2025 |
doi: 10.3389/fcvm.2025.1502205
The association between cardiovascular diseases and their subcategories with the severity of chronic obstructive pulmonary disease: A large cross-sectional study based on a Chinese hospital population cohort
Provisionally accepted- 1 Key Laboratory of Interventional Pulmonology of Zhejiang Province, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China
- 2 Nassau University Medical Center, East Meadow, New York, United States
- 3 Department of Pulmonary and Critical Care Medicine, Quzhou City People's Hospital, Quzhou, China
Background Current evidence suggests that cardiovascular disease (CVD) plays a role in the progression of chronic obstructive pulmonary disease (COPD). However, the relationship between CVD and the severity of COPD remains inadequately understood. Therefore, this study aims to elucidate the association between CVD and the severity of COPD.In this cross-sectional study involving 7,152 individuals with COPD., Logistic regression, subgroup and sensitivity analyses were employed to evaluate the association between CVD, its subcategories, and the severity of COPD.Multivariable logistic regression analysis showed that CVD and hypertension remained independently associated with COPD severity (P < 0.001). Patients with CVD had a 1.701 times higher risk of developing severe or very severe COPD compared to those without CVD, while patients with hypertension had a 1.686 times higher risk of developing severe or very severe COPD compared to those without hypertension (P < 0.05).Subgroup analyses showed that the association between CVD and COPD severity remained stable among men, patients ≤ 70 years of age, patients > 70 years of age, BMI < 24 or ≥ 24 kg/m 2 , and never smokers, whereas coronary artery disease was significantly associated with COPD severity only among patients ≤ 70 years of age and never smokers (P < 0.05). In addition, hypertension was also stably associated with COPD severity among men, patients ≤ 70 years of age, patients > 70 years of age, BMI < 24 or ≥ 24 kg/m 2 , and never smokers.Sensitivity analyses reconfirmed the robustness of the associations of CVD and hypertension with COPD severity among patients who excluded bronchiectasis, tuberculosis, lung cancer, pulmonary hypertension, pulmonary heart disease, and diabetes (P < 0.05).The strong association between CVD and its subcategories (mainly hypertension) and the severity of COPD suggests that the potential risk of exacerbation of CVD should also be addressed in the clinical management of patients with COPD. However, limitations of the cross-sectional design may limit the , 删除:. 删除:CVD was treated as exposure factors, while COPD severity was considered the outcome factor.
Keywords: gender, Smoking frequency, BMI, Chronic airway disease, chronic bronchitis, Chronic rhinitis, and emphysema Chronic obstructive pulmonary disease, cardiovascular disease
Received: 26 Sep 2024; Accepted: 27 Jan 2025.
Copyright: © 2025 Li, Chen, Xu, Zheng, Yang, Zhao and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Tianye Li, Key Laboratory of Interventional Pulmonology of Zhejiang Province, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China
Hao Xu, Department of Pulmonary and Critical Care Medicine, Quzhou City People's Hospital, Quzhou, 324000, China
Yanhong Zheng, Department of Pulmonary and Critical Care Medicine, Quzhou City People's Hospital, Quzhou, 324000, China
Heying Yang, Key Laboratory of Interventional Pulmonology of Zhejiang Province, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China
Hongjun Zhao, Department of Pulmonary and Critical Care Medicine, Quzhou City People's Hospital, Quzhou, 324000, China
Chengshui Chen, Department of Pulmonary and Critical Care Medicine, Quzhou City People's Hospital, Quzhou, 324000, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.